Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Spyral InSight Study

NCT: NCT07013929 · RECRUITING

NCT IDNCT07013929
StatusRECRUITING
Start Date2025-06-09
Completion2027-07-01
SponsorMedtronic Vascular (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the Spyral InSight Early Clinical Feasibility Study is to characterize the physiological response to renal nerve stimulation (RNS) in humans prior to and post renal denervation.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑